8c8876e53b6f3cd9…
StudyID:
NCT00095719686 bytesFirst seen Jun 12, 20261 collectionFields
| Name | Value |
|---|---|
| briefSummary | The purpose of this trial is to test the safety \& tolerability of intramuscular aripiprazole in acutely agitated patients diagnosed with Dementia. |
| completionDate | 2005-03 |
| conditions | ["Dementia","Alzheimer's Disease"] |
| enrollmentCount | 125 |
| enrollmentType | null |
| nctId | NCT00095719 |
| phase | PHASE3 |
| sponsorId | otsuka-pharmaceutical-development-commercialization-inc |
| startDate | 2003-12 |
| status | COMPLETED |
| studyType | INTERVENTIONAL |
| title | A Safety & Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia |
| url | https://clinicaltrials.gov/study/NCT00095719 |
Canonical JSON
{
"id": "NCT00095719",
"type": "Study",
"data": {
"briefSummary": "The purpose of this trial is to test the safety \\& tolerability of intramuscular aripiprazole in acutely agitated patients diagnosed with Dementia.",
"completionDate": "2005-03",
"conditions": [
"Dementia",
"Alzheimer's Disease"
],
"enrollmentCount": 125,
"enrollmentType": null,
"nctId": "NCT00095719",
"phase": "PHASE3",
"sponsorId": "otsuka-pharmaceutical-development-commercialization-inc",
"startDate": "2003-12",
"status": "COMPLETED",
"studyType": "INTERVENTIONAL",
"title": "A Safety & Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia",
"url": "https://clinicaltrials.gov/study/NCT00095719"
}
}Appears in 1 collection
nih/clinical-trials1 version · Jun 12, 2026
Full hash:8c8876e53b6f3cd96c15a751b599767bcf25c459541d0e78b4ee942984809366